(Q28316018)

title

A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action (English)

0 references

1 reference

G. J. Marek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1365657

18 September 2022

C. J. McDougle

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1365657

18 September 2022

L. H. Price

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1365657

18 September 2022

L. S. Seiden

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1365657

18 September 2022

language of work or name

English

0 references

publication date

1992

0 references

number of pages

10

1 reference

Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine.

inferred from page(s)

published in

Psychopharmacology

0 references

volume

109

0 references

page(s)

2-11

0 references

issue

1-2

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02245475

Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245475

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245475

Antagonism of phenylephrine-evoked sweating by trazodone and amitriptyline in humans in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245475

Trazodone in the treatment of panic disorder and agoraphobia with panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245475

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245475

Clinical Effects of the 5-HT1A Partial Agonists in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245475

Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245475

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder

21 January 2018

1 reference

12 December 2020

Trazodone in the treatment of depressed inpatients

1 reference

12 December 2020

Two distinct effects of 5-hydroxytryptamine on single cortical neurons.

1 reference

12 December 2020

Effects of trazodone treatment on serotonergic function in depressed patients.

1 reference

12 December 2020

Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system

1 reference

12 December 2020

Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

1 reference

12 December 2020

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

1 reference

12 December 2020

Panic disorder: a treatment update

1 reference

12 December 2020

The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression

1 reference

12 December 2020

Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.

1 reference

12 December 2020

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

12 December 2020

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

1 reference

12 December 2020

Biochemical investigations into the mode of action of trazodone

1 reference

12 December 2020

Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults.

1 reference

12 December 2020

Selective inhibition of serotonin uptake by trazodone, a new antidepressant agent

1 reference

12 December 2020

Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule.

1 reference

12 December 2020

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline

1 reference

12 December 2020

Comparative effects of trazodone and tricyclic antidepressants on uptake of selected neurotransmitters by isolated rat brain synaptosomes

1 reference

12 December 2020

Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodone

1 reference

12 December 2020

Prolactin response to tryptophan during mianserin treatment

1 reference

12 December 2020

Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine

1 reference

12 December 2020

A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder

1 reference

12 December 2020

Fluoxetine versus trazodone in the treatment of outpatients with major depression.

1 reference

12 December 2020

Nefazodone: preclinical pharmacology of a new antidepressant

1 reference

12 December 2020

Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: evidence for the involvement of a 5-HT2-activated interneuron

1 reference

12 December 2020

Sleep disorders in patients with severe mental depression: Double-blind placebo-controlled evaluation of the value of pipamperone (Dipiperon®)

1 reference

12 December 2020

Efficacy of fluvoxamine in treatment-refractory depression.

1 reference

12 December 2020

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

1 reference

12 December 2020

Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors

1 reference

12 December 2020

The development of cortical β-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserine

1 reference

12 December 2020

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin.

1 reference

12 December 2020

A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder

1 reference

12 December 2020

Properties of some 1-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents

1 reference

12 December 2020

Fluoxetine in depressed patients: a comparison with imipramine

1 reference

12 December 2020

Therapeutic effects of serotonin uptake inhibitors in depression

1 reference

12 December 2020

Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex.

1 reference

12 December 2020

(—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone

1 reference

12 December 2020

Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain.

1 reference

12 December 2020

Effector systems coupled to serotonin receptors in brain: serotonin stimulated phosphoinositide hydrolysis

1 reference

12 December 2020

Mode of action of antidepressant drugs

1 reference

12 December 2020

Pizotifen as an antidepressant

1 reference

12 December 2020

Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone

1 reference

12 December 2020

Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients

1 reference

12 December 2020

The side effect profile and safety of fluoxetine

1 reference

12 December 2020

Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression

1 reference

12 December 2020

5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat

1 reference

12 December 2020

Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro

1 reference

12 December 2020

Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action

1 reference

12 December 2020

Serotonin function and human anxiety disorders

1 reference

12 December 2020

Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder.

1 reference

12 December 2020

Dimensions Publication ID

Identifiers

DOI

10.1007/BF02245475

0 references

1014104554

0 references